Early Lung Cancer Patient Journey in Singapore: Challenges and Recommendations.

IF 1.4 4区 医学 Q4 ONCOLOGY
Lynette Teo, Mariko Siyue Koh, Kevin Lee Min Chua, Lowell Leow, Chong Hee Lim, Darren Wan-Teck Lim, Hong Liang Lim, Hwai Loong Kong, Gideon Ooi, Jens Samol, Chee Seng Tan, Ross A Soo
{"title":"Early Lung Cancer Patient Journey in Singapore: Challenges and Recommendations.","authors":"Lynette Teo, Mariko Siyue Koh, Kevin Lee Min Chua, Lowell Leow, Chong Hee Lim, Darren Wan-Teck Lim, Hong Liang Lim, Hwai Loong Kong, Gideon Ooi, Jens Samol, Chee Seng Tan, Ross A Soo","doi":"10.1111/ajco.14180","DOIUrl":null,"url":null,"abstract":"<p><p>Early detection of lung cancer is crucial for improving survival rates because it allows for potentially curative treatments; however, most lung cancer cases in Singapore are diagnosed at advanced stages. This review article provides an overview of current practices in the management of early-stage non-small-cell lung cancer (stages I-IIIA) in Singapore (i.e., screening, diagnosis, treatment, and follow-up) while identifying and addressing the associated challenges. Implementing a locally adapted, subsidized national screening program with awareness campaigns can facilitate lung cancer screening uptake. Improving the accessibility and affordability of diagnostic tests and treatments, establishing clear referral pathways and diagnostic workup, adopting multidisciplinary teams, and utilizing cost-effective treatments are critical to timely and effective management of early-stage lung cancers. Establishment of local guidelines for follow-up care, integrating digital technologies and artificial intelligence, and expanding patient assistance programs for follow-up procedures are vital to improving long-term outcomes. Overall, improving the management of early-stage lung cancer necessitates collaboration among healthcare professionals, medical societies, policymakers, patient advocacy groups, and the general public.</p>","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Pacific journal of clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ajco.14180","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Early detection of lung cancer is crucial for improving survival rates because it allows for potentially curative treatments; however, most lung cancer cases in Singapore are diagnosed at advanced stages. This review article provides an overview of current practices in the management of early-stage non-small-cell lung cancer (stages I-IIIA) in Singapore (i.e., screening, diagnosis, treatment, and follow-up) while identifying and addressing the associated challenges. Implementing a locally adapted, subsidized national screening program with awareness campaigns can facilitate lung cancer screening uptake. Improving the accessibility and affordability of diagnostic tests and treatments, establishing clear referral pathways and diagnostic workup, adopting multidisciplinary teams, and utilizing cost-effective treatments are critical to timely and effective management of early-stage lung cancers. Establishment of local guidelines for follow-up care, integrating digital technologies and artificial intelligence, and expanding patient assistance programs for follow-up procedures are vital to improving long-term outcomes. Overall, improving the management of early-stage lung cancer necessitates collaboration among healthcare professionals, medical societies, policymakers, patient advocacy groups, and the general public.

新加坡早期肺癌患者之旅:挑战和建议。
肺癌的早期发现对于提高生存率至关重要,因为它可以提供潜在的治愈治疗;然而,新加坡的大多数肺癌病例都是在晚期被诊断出来的。这篇综述文章概述了目前新加坡早期非小细胞肺癌(I-IIIA期)的管理实践(即筛查、诊断、治疗和随访),同时确定并解决相关挑战。实施适合当地的、有补贴的国家筛查方案,并开展宣传活动,可促进肺癌筛查的普及。改善诊断检测和治疗的可及性和可负担性,建立明确的转诊途径和诊断检查,采用多学科团队,以及利用具有成本效益的治疗方法,对于及时有效地管理早期肺癌至关重要。建立随访护理的地方指南,整合数字技术和人工智能,以及扩大随访程序的患者援助计划,对于改善长期结果至关重要。总的来说,改善早期肺癌的管理需要医疗保健专业人员、医学协会、决策者、患者倡导团体和公众之间的合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.40
自引率
0.00%
发文量
175
审稿时长
6-12 weeks
期刊介绍: Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信